Athersys (ATHX) - P/S ratio

P/S ratio on March 12, 2024 (TTM) : 10.4

According to Athersys's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.0229. At the end of 2023 the company had a P/S ratio of 144.

P/S ratio history for Athersys from 2008 to 2023

PS ratio at the end of each year

Year	P/S ratio	Change
2023	144	5214.19%
2022	2.72	-92.95%
2021	38.5	-84.4%
2020	247	592.84%
2019	35.6	306.98%
2018	8.75	-88.4%
2017	75.5	833.48%
2016	8.08	-3.46%
2015	8.37	-98.05%
2014	429	83.42%
2013	234	2528.81%
2012	8.90	126.49%
2011	3.93	-24.85%
2010	5.23	-85.55%
2009	36.2	1219.72%
2008	2.74

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Johnson & Johnson JNJ	5.83	-44.01%	🇺🇸 USA
Pfizer PFE	2.40	-76.92%	🇺🇸 USA
Amgen AMGN	4.80	-53.91%	🇺🇸 USA
Sanofi SNY	2.06	-80.25%	🇫🇷 France
Merck MRK	4.28	-58.93%	🇺🇸 USA
Bristol-Myers Squibb BMY	2.49	-76.12%	🇺🇸 USA
United States Lime & Minerals USLM	8.57	-17.74%	🇺🇸 USA
Moderna MRNA	9.19	-11.73%	🇺🇸 USA
Arena Pharmaceuticals ARNA	N/A	N/A	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Athersys (ATHX)

P/S ratio on March 12, 2024 (TTM) : 10.4